APPLICATION
ANDA065012
TYPE
ANDA
ORIGINAL APPROVAL
2000-07-03
LATEST ACTION
2007-11-26
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
CEFOXITINDiscontinued
CEFOXITIN SODIUM EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · INJECTABLE · INJECTION
CEFOXITINDiscontinued
CEFOXITIN SODIUM EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · INJECTABLE · INJECTION
Approval history
2007-11-26Labeling · Supplement 7AP
2004-02-13Labeling · Supplement 3AP
2001-07-23Manufacturing (CMC) · Supplement 2AP
2000-12-22Labeling · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.